MORELLI, EUGENIO
 Distribuzione geografica
Continente #
NA - Nord America 313
AS - Asia 202
EU - Europa 114
SA - Sud America 13
AF - Africa 5
OC - Oceania 1
Totale 648
Nazione #
US - Stati Uniti d'America 306
SG - Singapore 121
IT - Italia 53
CN - Cina 30
IN - India 23
DE - Germania 22
VN - Vietnam 13
GB - Regno Unito 11
BR - Brasile 9
SE - Svezia 8
BD - Bangladesh 6
CA - Canada 6
FI - Finlandia 6
HK - Hong Kong 5
CZ - Repubblica Ceca 3
NL - Olanda 3
EC - Ecuador 2
EG - Egitto 2
LT - Lituania 2
PK - Pakistan 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
ES - Italia 1
ET - Etiopia 1
HU - Ungheria 1
IQ - Iraq 1
JP - Giappone 1
MX - Messico 1
NO - Norvegia 1
RU - Federazione Russa 1
TN - Tunisia 1
UA - Ucraina 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 648
Città #
Singapore 77
Chandler 72
Dallas 31
Munich 18
Santa Clara 16
Bengaluru 15
Hefei 15
Ashburn 11
Lawrence 11
Princeton 11
Catanzaro 10
London 10
Milan 10
Chicago 9
Ho Chi Minh City 6
Hong Kong 5
New York 5
Turku 5
Beijing 4
Los Angeles 4
Montreal 4
Rome 4
Boardman 3
Charlotte 3
Olomouc 3
San Francisco 3
São Paulo 3
Tongi 3
Wilmington 3
6th of October City 2
Ahmedabad 2
Bari 2
Can Tho 2
Da Nang 2
Naples 2
San Nicola Manfredi 2
Addis Ababa 1
Andover 1
Barcarena 1
Barueri 1
Basti 1
Biên Hòa 1
Bocale 1
Boituva 1
Boston 1
Brooklyn 1
Chennai 1
Cincinnati 1
Council Bluffs 1
Dhaka 1
Duhok 1
Fayetteville 1
Graham 1
Greenville 1
Guangzhou 1
Hacienda Ibarra 1
Hanoi 1
Hanover 1
Helsinki 1
Houston 1
Ipiaú 1
Itabira 1
Jacareí 1
Jaipur 1
Jhelum 1
Jinhua 1
Kollam 1
La Marsa 1
Lucknow 1
Melbourne 1
Messina 1
Mexico City 1
Mountain View 1
Novokuznetsk 1
Nuremberg 1
Ottawa 1
Peshawar 1
Phoenix 1
Portland 1
Quito 1
Redmond 1
Resistencia 1
San Mateo 1
Stockholm 1
Tallahassee 1
Tokyo 1
Torino 1
Upington 1
Uppsala 1
Valencia 1
Vienna 1
Totale 443
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 95
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 57
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 52
In Vitro Silencing of lncRNAs Using LNA GapmeRs 51
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network 48
Inhibitor of DNA binding 2 (ID2) regulates key transcriptional programs in multiple myeloma 46
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 43
The non-coding RNA landscape of plasma cell dyscrasias 43
null 43
JunB is a key regulator of multiple myeloma bone marrow angiogenesis 41
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 39
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 36
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells (CO-FIRST AUTHOR) 32
Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis (Leukemia, (2021), 35, 12, (3509-3525), 10.1038/s41375-021-01271-9) 27
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 17
Totale 670
Categoria #
all - tutte 6.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 1 0 0 1 0 0
2021/202235 1 0 0 6 0 0 6 4 9 4 3 2
2022/2023164 23 15 11 5 22 13 0 21 29 12 10 3
2023/202471 15 15 3 10 2 14 3 1 1 0 1 6
2024/2025197 21 5 10 15 13 40 8 6 6 2 27 44
2025/2026180 32 40 34 30 41 3 0 0 0 0 0 0
Totale 670